BriaCell Provides Clinical Update on its Lead Immunotherapy Drug in Advanced Breast Cancer – GlobeNewswire (press release)
|
BriaCell Provides Clinical Update on its Lead Immunotherapy Drug in Advanced Breast Cancer
GlobeNewswire (press release) The combination rollover study, BRI-ROL-001, is available to enroll patients. Other activities remain on track. The companion diagnostic, BriaDX™, has been bolstered by the important supporting data for the HLA biomarker matching hypothesis noted … |
